U.S. Markets close in 2 hrs 39 mins

Bellicum Pharmaceuticals, Inc. (BLCM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.10-0.40 (-5.28%)
As of 1:17PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-32.43%
S&P500 52-Week Change 3N/A
52 Week High 327.90
52 Week Low 33.32
50-Day Moving Average 37.54
200-Day Moving Average 37.56

Share Statistics

Avg Vol (3 month) 367.46k
Avg Vol (10 day) 330.68k
Shares Outstanding 55.06M
Float 5.03M
% Held by Insiders 10.24%
% Held by Institutions 133.48%
Shares Short (Jul 14, 2020) 4411.46k
Short Ratio (Jul 14, 2020) 47.32
Short % of Float (Jul 14, 2020) 48.17%
Short % of Shares Outstanding (Jul 14, 2020) 48.15%
Shares Short (prior month Jun 14, 2020) 4401.14k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Feb 05, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-1,249.25%

Management Effectiveness

Return on Assets (ttm)-50.42%
Return on Equity (ttm)-6,120.17%

Income Statement

Revenue (ttm)5.24M
Revenue Per Share (ttm)1.06
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-55.33M
EBITDA -61.05M
Net Income Avi to Common (ttm)-86.63M
Diluted EPS (ttm)-17.50
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)66.41M
Total Cash Per Share (mrq)13.12
Total Debt (mrq)28.2M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.87
Book Value Per Share (mrq)-9.64

Cash Flow Statement

Operating Cash Flow (ttm)-61.99M
Levered Free Cash Flow (ttm)26.77M